Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Zhang

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Journal of Clinical Pharmacology|February 26, 2013
Inhibitory effect of ketoconazole on the pharmacokinetics of a multireceptor tyrosine kinase inhibitor BMS-690514 in healthy participants: assessing the mechanism of the interaction with physiologically-based pharmacokinetic simulationsZheng Yang, Blisse Vakkalagadda, Guoxiang Shen, et al.
Clinical Pharmacology in Drug Development|January 16, 2025
A Drug-Drug Interaction Study of Mobocertinib and Midazolam, a Cytochrome P450 3A Substrate, in Patients With Advanced Non-Small Cell Lung CancerMichael J Hanley, Steven Zhang, Nick Pavlakis, et al.
Investigational New Drugs|September 22, 2017
A phase I study to assess the mass balance, excretion, and pharmacokinetics of [<sup>14</sup>C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumorsNeeraj Gupta, Steven Zhang, Sandeepraj Pusalkar, et al.
Blood|March 14, 2007
A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemiaJean-Luc Harousseau, Jeffrey E Lancet, Josy Reiffers, et al.
ACS Applied Materials & Interfaces|September 24, 2020
Porosity Modulated High-Performance Piezoelectric Nanogenerator Based on Organic/Inorganic Nanomaterials for Self-Powered Structural Health MonitoringMd Masud Rana, Asif Abdullah Khan, Guangguang Huang, et al.
Neurobiology of Disease|August 8, 2009
Mice deficient in dihydrolipoyl succinyl transferase show increased vulnerability to mitochondrial toxinsLichuan Yang, Qingli Shi, Daniel J Ho, et al.
Molecular Cell|July 14, 2019
Nuclear TARBP2 Drives Oncogenic Dysregulation of RNA Splicing and DecayLisa Fish, Albertas Navickas, Bruce Culbertson, et al.
Oncotarget|December 10, 2016
MicroRNA-203 predicts human survival after resection of colorectal liver metastasisT Peter Kingham, Hoang C B Nguyen, Jian Zheng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 30, 2010
Metabolism and disposition of [14C]BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor, after oral administration to humansLisa J Christopher, Haizheng Hong, Blisse J Vakkalagadda, et al.
Science (New York, N.Y.)|May 14, 2021
A prometastatic splicing program regulated by SNRPA1 interactions with structured RNA elementsLisa Fish, Matvei Khoroshkin, Albertas Navickas, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Journal of Clinical Pharmacology|February 26, 2013
Inhibitory effect of ketoconazole on the pharmacokinetics of a multireceptor tyrosine kinase inhibitor BMS-690514 in healthy participants: assessing the mechanism of the interaction with physiologically-based pharmacokinetic simulationsZheng Yang, Blisse Vakkalagadda, Guoxiang Shen, et al.
Clinical Pharmacology in Drug Development|January 16, 2025
A Drug-Drug Interaction Study of Mobocertinib and Midazolam, a Cytochrome P450 3A Substrate, in Patients With Advanced Non-Small Cell Lung CancerMichael J Hanley, Steven Zhang, Nick Pavlakis, et al.
Investigational New Drugs|September 22, 2017
A phase I study to assess the mass balance, excretion, and pharmacokinetics of [<sup>14</sup>C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumorsNeeraj Gupta, Steven Zhang, Sandeepraj Pusalkar, et al.
Blood|March 14, 2007
A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemiaJean-Luc Harousseau, Jeffrey E Lancet, Josy Reiffers, et al.
ACS Applied Materials & Interfaces|September 24, 2020
Porosity Modulated High-Performance Piezoelectric Nanogenerator Based on Organic/Inorganic Nanomaterials for Self-Powered Structural Health MonitoringMd Masud Rana, Asif Abdullah Khan, Guangguang Huang, et al.
Neurobiology of Disease|August 8, 2009
Mice deficient in dihydrolipoyl succinyl transferase show increased vulnerability to mitochondrial toxinsLichuan Yang, Qingli Shi, Daniel J Ho, et al.
Molecular Cell|July 14, 2019
Nuclear TARBP2 Drives Oncogenic Dysregulation of RNA Splicing and DecayLisa Fish, Albertas Navickas, Bruce Culbertson, et al.
Oncotarget|December 10, 2016
MicroRNA-203 predicts human survival after resection of colorectal liver metastasisT Peter Kingham, Hoang C B Nguyen, Jian Zheng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 30, 2010
Metabolism and disposition of [14C]BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor, after oral administration to humansLisa J Christopher, Haizheng Hong, Blisse J Vakkalagadda, et al.
Science (New York, N.Y.)|May 14, 2021
A prometastatic splicing program regulated by SNRPA1 interactions with structured RNA elementsLisa Fish, Matvei Khoroshkin, Albertas Navickas, et al.
Pageof 7